Azilsaltan Tablets (Azilva Tablets) Special Drug Use Surveillance "Hypertension Complicated by Diabetes "
Status:
Completed
Trial end date:
2016-02-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of azilsartan tablets (Azilva Tablets)
in patients with hypertension complicated by diabetes mellitus whose blood pressure cannot be
sufficiently reduced by monotherapy with angiotensin II receptor blockers (ARBs) other than
azilsartan, in routine clinical practice